# Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage

Study · id `cardio:ct-nct03209830` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03209830](<https://clinicaltrials.gov/study/NCT03209830>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03209830

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03209830. Randomized; double masking; primary purpose treatment. Start 2017-09-05 (actual); primary completion 2019-09-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03209830, source copy `cardio:ctgov-nct03209830-2019-11-22`, retrieved 2026-10-26)
- Started: 2017-09-05 (actual) (ClinicalTrials.gov record NCT03209830, source copy `cardio:ctgov-nct03209830-2019-11-22`, retrieved 2026-10-26)
- Primary completion: 2019-09-13 (actual) (ClinicalTrials.gov record NCT03209830, source copy `cardio:ctgov-nct03209830-2019-11-22`, retrieved 2026-10-26)
- Completion: 2019-09-13 (actual) (ClinicalTrials.gov record NCT03209830, source copy `cardio:ctgov-nct03209830-2019-11-22`, retrieved 2026-10-26)
- Countries: Norway (ClinicalTrials.gov record NCT03209830, source copy `cardio:ctgov-nct03209830-2019-11-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03209830-2019-11-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage
- Condition: Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug): OSU 6162
- Intervention (Drug): Placebo Oral Tablet
- Lead sponsor: Oslo University Hospital
- Lead sponsor class: OTHER
- Collaborator: Göteborg University
- Collaborator class: OTHER
- Collaborator: Sahlgrenska University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Oslo University Hospital (`cardio:org-oslo-university-hospital`)
- Registry lists this organization as a collaborator: Göteborg University (`cardio:org-goteborg-university`)
- Registry lists this organization as a collaborator: Sahlgrenska University Hospital (`cardio:org-sahlgrenska-university-hospital`)

## Provenance

Content hash: 1ebf411e81afc26f86676e35f89e84adadaa5b15f9faab4e9715dca4bb687d51
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
